Privia Health Group (NASDAQ:PRVA) Now Covered by Needham & Company LLC

Needham & Company LLC initiated coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report sent to investors on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $25.00 target price on the stock.

A number of other research firms have also weighed in on PRVA. Macquarie assumed coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. Stephens restated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Barclays lifted their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $20.51 on Friday. Privia Health Group has a one year low of $15.92 and a one year high of $23.24. The company’s 50-day simple moving average is $20.93 and its 200 day simple moving average is $19.43. The firm has a market capitalization of $2.46 billion, a P/E ratio of 205.12, a PEG ratio of 5.45 and a beta of 0.85.

Institutional Investors Weigh In On Privia Health Group

Large investors have recently made changes to their positions in the company. Nordea Investment Management AB boosted its holdings in shares of Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after buying an additional 86,910 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after acquiring an additional 14,641 shares during the last quarter. Franklin Resources Inc. grew its position in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after acquiring an additional 28,480 shares during the period. Virtu Financial LLC purchased a new stake in shares of Privia Health Group in the 3rd quarter worth $263,000. Finally, Neo Ivy Capital Management bought a new position in Privia Health Group in the 3rd quarter worth $66,000. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.